Keywords: مهار تکمیلی; Complement inhibition; Tumor immune evasion; CD46; CD55; CD59
مقالات ISI مهار تکمیلی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
C3-mediated extravascular hemolysis in PNH on eculizumab: Mechanism and clinical implications
Keywords: مهار تکمیلی; Paroxysmal nocturnal hemoglobinuria; complement inhibition; intravascular hemolysis; extravascular hemolysis; C3; C5;
Treatment of Myasthenia Gravis
Keywords: مهار تکمیلی; Myasthenia gravis; Pyridostigmine; Prednisone; Thymectomy; Immunotherapy; Complement inhibition; Intravenous immunoglobulin; Plasma exchange;
Effects of complement inhibition on the ABC phenomenon in rats
Keywords: مهار تکمیلی; ABC phenomenon; PEGylated nanoemulsions; Complement inhibition; Cobra venom factor;
Structure characterization of two novel polysaccharides isolated from the spikes of Prunella vulgaris and their anticomplement activities
Keywords: مهار تکمیلی; Prunella vulgaris; Polysaccharides; Complement inhibition
Microvesicles released constitutively from prostate cancer cells differ biochemically and functionally to stimulated microvesicles released through sublytic C5b-9
Keywords: مهار تکمیلی; Constitutive microvesicles; Stimulated microvesicles; Complement inhibition;
Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration
Keywords: مهار تکمیلی; Liver ischemia-reperfusion injury; Regeneration; Complement system; Complement inhibition; Acute liver failure
The effect of C1 inhibitor on myocardial ischemia and reperfusion injury
Keywords: مهار تکمیلی; Myocardial ischemia and reperfusion; Complement inhibition; Leukocyte transmigration;
Purification, cloning and characterization of a metalloproteinase from Naja atra venom
Keywords: مهار تکمیلی; Metalloproteinase; Complement; Complement inhibition; Fibrinogenase; Cobra venomfB, factor B; fD, factor D; NHS, normal human serum; VBS, veronal buffered saline; GGVB2+, VBS containing gelatin, Ca2+, Mg2+ and glucose; EA, antibody-sensitized sheep erythr
A protein-bound polysaccharide from the stem bark of Eucommia ulmoides and its anti-complementary effect
Keywords: مهار تکمیلی; Eucommia ulmoides; Polysaccharide; EWDS-2; Complement inhibition
Identification of a complement receptor 1 peptide for inhibition of immune hemolysis
Keywords: مهار تکمیلی; Complement receptor 1; CD35; Complement inhibition; Transfusion therapy; Hemolysis; Homology modeling; Mouse model; Transfusion reactions; CR1 peptides; C3a; C3b;
Synthesis of 3H-spiro[benzofuran-2,1′-cyclohexane] derivatives from naturally occurring filifolinol and their classical complement pathway inhibitory activity
Keywords: مهار تکمیلی; Filifolinol; Complement inhibition; 3H-spiro[benzofuran-2,1′-cyclohexanes]; Analogs of K76
Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement
Keywords: مهار تکمیلی; ADAM; A disintegrin and metalloproteinase family; CFA; cobra factor acidic; CFB; cobra factor basic; CVF; cobra venom factor; EA; sheep erythrocytes sensitized with rabbit IgG; H-CoF; high molecular weight cobra factor; HPLC; high performance liquid chrom